Yoshihiro Noguchi

Loop profile Researcher Name Resolver ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 50

Top Topics

Combination Therapy

Multiple Myeloma

Gastroesophageal Reflux Disease

Top Venues

Clinical pharmacology and therapeutics

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Yoshihiro Noguchi, Miao Yan, Tomoya Tachi, Tomoaki Yoshimura
Correspondence on 'Cardiovascular toxicities associated with bispecific T-cell engager therapy' by Sayed et al . Journal for immunotherapy of cancer 12 (4) (2024)
Yoshihiro Noguchi, Tomoaki Yoshimura
Detection Algorithms for Simple Two-Group Comparisons Using Spontaneous Reporting Systems. Drug safety (2024)
Yoshihiro Noguchi, Miao Yan, Tomoya Tachi, Tomoaki Yoshimura
Correspondence on 'Cardiovascular toxicities associated with bispecific T-cell engager therapy' by Sayed et al . Journal for immunotherapy of cancer 12 (4) (2024)
Yoshihiro Noguchi, Rikuto Masuda, Masataka Shishido, Tomoaki Yoshimura
Association between duration of action of benzodiazepine hypnotic drugs and blepharospasm: A disproportionality analysis study using FDA Adverse Events Reporting System. Journal of evidence-based medicine (2024)
Makiko Go, Yoshihiro Noguchi, Rikuto Masuda, Hiroki Asano, Michio Kimura, Eiseki Usami, Tomoaki Yoshimura
Association between CDK4/6 inhibitors and drug-related osteonecrosis of the jaw: A pharmacoepidemiological study using the FDA Adverse Events Reporting System. International journal of cancer (2024)
Yoshihiro Noguchi, Miao Yan, Tomoya Tachi, Tomoaki Yoshimura
Correspondence on 'Cardiovascular toxicities associated with bispecific T-cell engager therapy' by Sayed et al . Journal for immunotherapy of cancer 12 (4) (2024)
Makiko Go, Yoshihiro Noguchi, Rikuto Masuda, Hiroki Asano, Michio Kimura, Eiseki Usami, Tomoaki Yoshimura
Association between CDK4/6 inhibitors and drug-related osteonecrosis of the jaw: A pharmacoepidemiological study using the FDA Adverse Events Reporting System. International journal of cancer 155 (5) (2024)
Makiko Go, Yoshihiro Noguchi, Rikuto Masuda, Hiroki Asano, Michio Kimura, Eiseki Usami, Tomoaki Yoshimura
Association between CDK4/6 inhibitors and drug-related osteonecrosis of the jaw: A pharmacoepidemiological study using the FDA Adverse Events Reporting System. International journal of cancer 155 (5) (2024)
Yoshihiro Noguchi, Rikuto Masuda, Haruka Aizawa, Tomoaki Yoshimura
Relationship Between Melatonin Receptor Agonists and Parkinson's Disease. Journal of pineal research 76 (5) (2024)
Yoshihiro Noguchi, Tomoaki Yoshimura
Detection Algorithms for Simple Two-Group Comparisons Using Spontaneous Reporting Systems. Drug safety 47 (6) (2024)
Makiko Go, Michio Kimura, Shiori Yamada, Eiseki Usami, Yoshihiro Noguchi, Tomoaki Yoshimura
Comparison of Safety and Treatment Continuity of Palbociclib and Abemaciclib for Hormone Receptor-Positive, HER2-Negative Metastatic/Recurrent Breast Cancer. Journal of pharmacy practice (2024)
Yoshihiro Noguchi, Tomoaki Yoshimura
Detection Algorithms for Simple Two-Group Comparisons Using Spontaneous Reporting Systems. Drug safety 47 (6) (2024)
Yoshihiro Noguchi, Tomoaki Yoshimura
Comment on: 'Drugs associated with epidermal necrolysis in children: A World Health Organization pharmacovigilance database analysis'. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Yoshihiro Noguchi, Miao Yan, Tomoya Tachi, Tomoaki Yoshimura
Correspondence on 'Cardiovascular toxicities associated with bispecific T-cell engager therapy' by Sayed et al . Journal for immunotherapy of cancer 12 (4) (2024)
Yoshihiro Noguchi, Tomoya Tachi, Tomoaki Yoshimura
Caveats of Covariate Adjustment in Disproportionality Analysis for Best Practices. Drug safety (2024)
Shuang Xia, Hui Gong, Yichang Zhao, Lin Guo, Yikun Wang, Rui Ma, Bikui Zhang, Mayur Sarangdhar, Yoshihiro Noguchi, Miao Yan
Tumor Lysis Syndrome Associated with Monoclonal Antibodies in Patients with Multiple Myeloma: A Pharmacovigilance Study Based on the FAERS Database. Clinical pharmacology and therapeutics (2023)
Yoshihiro Noguchi, Miao Yan, Tomoaki Yoshimura
Comment on: Drugs That Interact With Colchicine via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS). The Annals of pharmacotherapy (2023)
Yoshihiro Noguchi, Tomoaki Yoshimura
Is it possible to identify risk factors for adverse drug reactions using a pharmacovigilance database based on spontaneous reporting? Pharmacoepidemiology and drug safety (2023)
Yoshihiro Noguchi, Tomoaki Yoshimura
Comment on: Exploring the impact of design criteria for reference sets on performance evaluation of signal detection algorithms: The case of drug-drug interactions. Pharmacoepidemiology and drug safety (2023)
Yoshihiro Noguchi, Tomoaki Yoshimura
Comment: Detection of Vaccine Adverse Events Before Package Insert Revisions Using a Japanese Spontaneous Reporting System. Journal of clinical pharmacology (2023)
Shuang Xia, Hui Gong, Yichang Zhao, Lin Guo, Yikun Wang, Rui Ma, Bikui Zhang, Mayur Sarangdhar, Yoshihiro Noguchi, Miao Yan
Tumor lysis syndrome associated with monoclonal antibodies in patients with multiple myeloma: a pharmacovigilance study based on the FAERS database. Clinical pharmacology and therapeutics (2023)
Yoshihiro Noguchi, Miao Yan, Tomoaki Yoshimura
Questioning Bayesian Inference-Based Models for Estimating Culprit Drugs for Adverse Drug Reactions. Clinical pharmacology and therapeutics (2023)
Junlin Wu, Hanbiao Wu, Lili Chen, Haiping Liang, Guoning Huang, Sensen Yang, Bishan Chen, Yoshihiro Noguchi, Yonggang Shen
Safety of daratumumab in the real-world: a pharmacovigilance study based on FAERS database. Expert opinion on drug safety (2023)
Junlin Wu, Hanbiao Wu, Lili Chen, Haiping Liang, Guoning Huang, Sensen Yang, Bishan Chen, Yoshihiro Noguchi, Yonggang Shen
Safety of daratumumab in the real-world: a pharmacovigilance study based on FAERS database. Expert opinion on drug safety 23 (7) (2023)
Yoshihiro Noguchi, Tomoaki Yoshimura
Comment on: "Drug-associated kidney injury in children: a disproportionality analysis of the FDA adverse event reporting system". European journal of pediatrics (2023)
Junlin Wu, Hanbiao Wu, Lili Chen, Haiping Liang, Guoning Huang, Sensen Yang, Bishan Chen, Yoshihiro Noguchi, Yonggang Shen
Safety of daratumumab in the real-world: a pharmacovigilance study based on FAERS database. Expert opinion on drug safety (2023)
Shuang Xia, Hui Gong, Yichang Zhao, Lin Guo, Yikun Wang, Rui Ma, Bikui Zhang, Mayur Sarangdhar, Yoshihiro Noguchi, Miao Yan
Tumor lysis syndrome associated with monoclonal antibodies in patients with multiple myeloma: a pharmacovigilance study based on the FAERS database. Clinical pharmacology and therapeutics (2023)
Shuang Xia, Hui Gong, Yichang Zhao, Lin Guo, Yikun Wang, Rui Ma, Bikui Zhang, Mayur Sarangdhar, Yoshihiro Noguchi, Miao Yan
Tumor lysis syndrome associated with monoclonal antibodies in patients with multiple myeloma: a pharmacovigilance study based on the FAERS database. Clinical pharmacology and therapeutics (2023)
Yoshihiro Noguchi, Miao Yan
Comment on: "Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis". International journal of cancer (2023)
Hiroki Asano, Yoshihiro Noguchi, Michio Kimura, Eiseki Usami, Tomoaki Yoshimura
Pituitary-Related Adverse Events and Onset Patterns Caused by Immune Checkpoint Inhibitors: Analysis Using the Japanese Adverse Drug Event Report Database. Medicina (Kaunas, Lithuania) 59 (11) (2023)
Yoshihiro Noguchi, Miao Yan
Comment on: "Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis". International journal of cancer (2023)
Shuang Xia, Hui Gong, Yi-Chang Zhao, Lin Guo, Yikun Wang, Bikui Zhang, Mayur Sarangdhar, Yoshihiro Noguchi, Miao Yan
Association of Pulmonary Sepsis and Immune Checkpoint Inhibitors: A Pharmacovigilance Study. Cancers 15 (1) (2022)
Shuang Xia, Hui Gong, Yi-Chang Zhao, Lin Guo, Yikun Wang, Bikui Zhang, Mayur Sarangdhar, Yoshihiro Noguchi, Miao Yan
Association of Pulmonary Sepsis and Immune Checkpoint Inhibitors: A Pharmacovigilance Study. Cancers 15 (1) (2022)
Yoshihiro Noguchi
Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)". Drug safety 45 (12) (2022)
Yoshihiro Noguchi, Shunsuke Yoshizawa, Tomoya Tachi, Hitomi Teramachi
Effect of Dipeptidyl Peptidase-4 Inhibitors vs. Metformin on Major Cardiovascular Events Using Spontaneous Reporting System and Real-World Database Study. Journal of clinical medicine 11 (17) (2022)
Yoshihiro Noguchi, Tomoya Tachi, Hitomi Teramachi
Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source. Briefings in bioinformatics 22 (6) (2022)
Yoshihiro Noguchi
Comment on: "Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data". Drug safety 45 (7) (2022)
Shuang Xia, Hui Gong, Yi-Chang Zhao, Lin Guo, Yikun Wang, Bikui Zhang, Mayur Sarangdhar, Yoshihiro Noguchi, Miao Yan
Association of Pulmonary Sepsis and Immune Checkpoint Inhibitors: A Pharmacovigilance Study. Cancers 15 (1) (2022)
Shuang Xia, Hui Gong, Yi-Chang Zhao, Lin Guo, Yikun Wang, Bikui Zhang, Mayur Sarangdhar, Yoshihiro Noguchi, Miao Yan
Association of Pulmonary Sepsis and Immune Checkpoint Inhibitors: A Pharmacovigilance Study. Cancers 15 (1) (2022)
Yoshihiro Noguchi, Tomoya Tachi, Hitomi Teramachi
Comment on: 'Detecting drug-drug interactions that increase the incidence of long QT syndrome using a spontaneous reporting system' by Matsuo et al. Journal of clinical pharmacy and therapeutics 47 (5) (2021)
Yoshihiro Noguchi, Azusa Murayama, Hiroki Esaki, Mayuko Sugioka, Aisa Koyama, Tomoya Tachi, Hitomi Teramachi
Angioedema Caused by Drugs That Prevent the Degradation of Vasoactive Peptides: A Pharmacovigilance Database Study. Journal of clinical medicine 10 (23) (2021)
Tomoya Tachi, Manami Otsubo, Manabu Toyoshima, Hayato Katsuno, Anri Ueno, Yoshihiro Noguchi, Satoshi Aoyama, Masahiro Yasuda, Takashi Mizui, Chitoshi Goto, Hitomi Teramachi
What activities of daily living at discharge affect the discharge destination of patients in an acute-care hospital in Japan: A retrospective factor analysis. The International journal of health planning and management 36 (4) (2021)
Yoshihiro Noguchi, Shunsuke Yoshizawa, Keisuke Aoyama, Satoaki Kubo, Tomoya Tachi, Hitomi Teramachi
Verification of the "Upward Variation in the Reporting Odds Ratio Scores" to Detect the Signals of Drug-Drug Interactions. Pharmaceutics 13 (10) (2021)
Yoshihiro Noguchi, Tomoya Tachi, Hitomi Teramachi
Subset Analysis for Screening Drug-Drug Interaction Signal Using Pharmacovigilance Database. Pharmaceutics 12 (8) (2020)
Yoshihiro Noguchi, Mirai Takaoka, Tsuyoshi Hayashi, Tomoya Tachi, Hitomi Teramachi
Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database. Epilepsia 61 (9) (2020)
Yoshihiro Noguchi, Keisuke Aoyama, Satoaki Kubo, Tomoya Tachi, Hitomi Teramachi
Improved Detection Criteria for Detecting Drug-Drug Interaction Signals Using the Proportional Reporting Ratio. Pharmaceuticals (Basel, Switzerland) 14 (1) (2020)
Yoshihiro Noguchi, Hiroki Esaki, Azusa Murayama, Mayuko Sugioka, Aisa Koyama, Tomoya Tachi, Hitomi Teramachi
Association between dipeptidyl peptidase-4 inhibitor and aspiration pneumonia: disproportionality analysis using the spontaneous reporting system in Japan. European journal of clinical pharmacology 76 (2) (2019)
Yoshihiro Noguchi, Hayato Katsuno, Anri Ueno, Manami Otsubo, Aki Yoshida, Yuta Kanematsu, Ikuto Sugita, Hiroki Esaki, Tomoya Tachi, Teruo Tsuchiya, Hitomi Teramachi
Signals of gastroesophageal reflux disease caused by incretin-based drugs: a disproportionality analysis using the Japanese adverse drug event report database. Journal of pharmaceutical health care and sciences 4 (2018)
Satoshi Yokoyama, Satoko Yajima, Akari Shimauchi, Chihiro Sakai, Shuji Yamashita, Yoshihiro Noguchi, Yoko Ino, Kazuhiro Iguchi, Hitomi Teramachi
Oncology pharmacist contributions to treatment with oral anticancer agents in a Japanese community pharmacy setting. Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC 151 (6) (2018)
Yoshihiro Noguchi, Anri Ueno, Hayato Katsuno, Manami Otsubo, Aki Yoshida, Yuta Kanematsu, Ikuto Sugita, Tomoya Tachi, Teruo Tsuchiya, Hitomi Teramachi
Analyses of non-benzodiazepine-induced adverse events and prognosis in elderly patients based on the Japanese adverse drug event report database. Journal of pharmaceutical health care and sciences 4 (2018)